ZA200706738B - Crystalline forms of a known pyrrolidine factor xa inhibitor - Google Patents
Crystalline forms of a known pyrrolidine factor xa inhibitorInfo
- Publication number
- ZA200706738B ZA200706738B ZA200706738A ZA200706738A ZA200706738B ZA 200706738 B ZA200706738 B ZA 200706738B ZA 200706738 A ZA200706738 A ZA 200706738A ZA 200706738 A ZA200706738 A ZA 200706738A ZA 200706738 B ZA200706738 B ZA 200706738B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibitor
- factor
- crystalline forms
- pyrrolidine
- known pyrrolidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66487005P | 2005-03-24 | 2005-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200706738B true ZA200706738B (en) | 2009-08-26 |
Family
ID=36579560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200706738A ZA200706738B (en) | 2005-03-24 | 2007-08-14 | Crystalline forms of a known pyrrolidine factor xa inhibitor |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080194643A1 (pt) |
EP (1) | EP1891044A1 (pt) |
JP (1) | JP2006265254A (pt) |
KR (1) | KR20070107156A (pt) |
CN (1) | CN101146792A (pt) |
AR (1) | AR053564A1 (pt) |
AU (1) | AU2006226043A1 (pt) |
BR (1) | BRPI0609445A2 (pt) |
CA (1) | CA2602550A1 (pt) |
IL (1) | IL185208A0 (pt) |
MX (1) | MX2007010602A (pt) |
RU (1) | RU2368610C2 (pt) |
TW (1) | TW200700412A (pt) |
WO (1) | WO2006100565A1 (pt) |
ZA (1) | ZA200706738B (pt) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7030141B2 (en) | 2001-11-29 | 2006-04-18 | Christopher Franklin Bigge | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
WO2004087646A2 (de) | 2003-04-03 | 2004-10-14 | Merck Patent Gmbh | Pyrrolidin -1,2-dicarbonsäure-1-(phenylamid) -2- (4-(3-oxo-morpholin-4-yl)-phenylamid) derivate und verwandte verbindungen als inhibitoren des koagulationsfaktors xa zur behandlung von thromboembolischen erkrankungen |
DE102004045796A1 (de) * | 2004-09-22 | 2006-03-23 | Merck Patent Gmbh | Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung |
-
2006
- 2006-03-13 RU RU2007134868/04A patent/RU2368610C2/ru not_active IP Right Cessation
- 2006-03-13 BR BRPI0609445-7A patent/BRPI0609445A2/pt not_active IP Right Cessation
- 2006-03-13 US US11/909,368 patent/US20080194643A1/en not_active Abandoned
- 2006-03-13 MX MX2007010602A patent/MX2007010602A/es unknown
- 2006-03-13 CN CNA2006800093654A patent/CN101146792A/zh active Pending
- 2006-03-13 WO PCT/IB2006/000633 patent/WO2006100565A1/en active Application Filing
- 2006-03-13 AU AU2006226043A patent/AU2006226043A1/en not_active Abandoned
- 2006-03-13 CA CA002602550A patent/CA2602550A1/en not_active Abandoned
- 2006-03-13 KR KR1020077021901A patent/KR20070107156A/ko not_active Application Discontinuation
- 2006-03-13 EP EP06727345A patent/EP1891044A1/en not_active Withdrawn
- 2006-03-21 TW TW095109692A patent/TW200700412A/zh unknown
- 2006-03-23 AR ARP060101152A patent/AR053564A1/es unknown
- 2006-03-24 JP JP2006081926A patent/JP2006265254A/ja active Pending
-
2007
- 2007-08-12 IL IL185208A patent/IL185208A0/en unknown
- 2007-08-14 ZA ZA200706738A patent/ZA200706738B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2368610C2 (ru) | 2009-09-27 |
EP1891044A1 (en) | 2008-02-27 |
US20080194643A1 (en) | 2008-08-14 |
AU2006226043A1 (en) | 2006-09-28 |
RU2007134868A (ru) | 2009-04-27 |
BRPI0609445A2 (pt) | 2010-04-06 |
CN101146792A (zh) | 2008-03-19 |
MX2007010602A (es) | 2008-03-04 |
AR053564A1 (es) | 2007-05-09 |
TW200700412A (en) | 2007-01-01 |
IL185208A0 (en) | 2008-01-06 |
KR20070107156A (ko) | 2007-11-06 |
WO2006100565A1 (en) | 2006-09-28 |
JP2006265254A (ja) | 2006-10-05 |
CA2602550A1 (en) | 2006-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL178807A0 (en) | Factor xa inhibitors | |
HK1110866A1 (en) | Crystalline form of a quinolinone-carboxamide compound | |
IL177253A0 (en) | PYRROLE-DERIVATIVES AS FACTOR Xa INHIBITORS | |
HK1200440A1 (zh) | 種抑制劑的結晶形式 | |
IL194891A0 (en) | Factor xa inhibitors | |
TWI372749B (en) | Crystalline forms of a biphenyl compound | |
EP1708571A4 (en) | NEW CRYSTALLINE SALTS OF A DIPEPTIDYLPEPTIDASE IV HEMMER | |
IL189625A0 (en) | Novel cycloalkane carboxamides as factor xa inhibitors | |
GB0504995D0 (en) | Use of a compound | |
PT2094708E (pt) | Pirrolopirazina como inibidor da cinase syk | |
IL189036A0 (en) | Pharmaceutical composition comprising a dpp-iv inhibitor | |
IL177470A0 (en) | BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS | |
EP1807082A4 (en) | INHIBITOR COMPOUNDS OF XA FACTORS | |
EP1764075A4 (en) | HAMMER OF TISSUE FACTORING | |
PL2468724T3 (pl) | Synteza związków pirolidynowych | |
IL198864A0 (en) | New crystalline forms | |
GB0524017D0 (en) | Generation of a categorisation scheme | |
IL183825A0 (en) | Crystalline forms of a factor xa inhibitor | |
IL187981A0 (en) | Crystalline forms of a pyrrolotriazine compound | |
EP1858844A4 (en) | NEW CRYSTALLINE FORMS OF ANTIDIABETIC COMPOUNDS | |
IL195061A0 (en) | Crystalline forms of atorvastatin | |
EP1986997A4 (en) | NEW CRYSTALLINE HEMI-CALCIUM FORM OF ATORVASTATIN | |
ZA200806859B (en) | Novel crystalline compounds | |
IL185208A0 (en) | Crystalline forms of a known pyrrolidine factor xa inhibitor | |
EP1951257A4 (en) | CRYSTALLINE FORMS |